Postgraduate Course
Arun J. Sanyal, MD
Z. Reno Vlahcevic Professor of Medicine; Executive Director, Education Core Center for Clinical and Translational Research
Virginia Commonwealth University
Richmond, VA, US
Disclosure: Advisory Committee/Board Member: Gilead
Consultant: 89 BIO, Affimmune, Albireo, Allergan, AMRA, Ardelyx, BASF, Birdrock, Boehringer Ingelhiem, Chemomab, Conatus, Durect, Echosans, Enyo, Fractyl, Galectin, General Electric, Genfit, Hemoshear, Immuron, Indalo, Intercept, Jannsen, Lilly, Mallinkrodt, Merck, Nimbus, Novartis, Novo Nordisk, Perspectum, Pfizer, Poxel, Salix, Sanofi, Second Genome, Servier, Takeda, Terns, Teva, Zydus
Employee: Sanyal Bio
Grant/Research Support: Bristol Myers, Conatus, Echosans, Galectin, Gilead, Mallinkrodt, Novartis, Sequana
Stockholder/Ownership Interest (excluding diversified mutual funds): Akarna, Durect, Exhalenz, Genfit, Hemoshear, Indalo, Tiziana
Consultant and PI of their ongoing trial: Genfit
Royalities: Elseiver
royalties: UpToDate
VCU and I have a joint patent on lipidomic profile of NASH but I have no direct COI with: OWL
